Ivm is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Eli Lilly, or any of their subsidiaries
A meta-analysis published in PMC concluded that weight regain is common and drug-dependent following discontinuation of anti-obesity pharmacotherapies, emphasising the need for sustained, long-term treatment strategies to manage obesity as a chronic disease
Scientific breakthroughs continue to validate what ColonBroom users already experience: that supporting gut health and GLP-1 production creates cascading benefits throughout the body
The experimental drug retatrutide delivered another round of impressive weight loss and blood sugar management results, according to phase 3 clinical trials results shared by drugmaker Eli Lilly
Fact Medical supervision allows providers to safely adjust dosing, monitor progress, and personalize treatment plans
These findings suggest that the pathophysiological links between PD and RLS may involve mechanisms beyond the dopaminergic pathway